SXTC
NASDAQ · Pharmaceuticals
China Sxt Pharmaceuticals In
$2.83
-0.10 (-3.41%)
Open$2.93
Previous Close$2.93
Day High$3.07
Day Low$2.81
52W High$8,375,840.00
52W Low—
Volume—
Avg Volume784.4K
Market Cap2.26M
P/E Ratio—
EPS$-7.95
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.16M | 1.40M | 998.7K |
| Net Income | -6,337,640 | -6,849,034 | 158.4K |
| Profit Margin | -545.2% | -518.0% | 15.9% |
| EBITDA | -7,205,839 | -8,219,917 | 317.7K |
| Free Cash Flow | — | — | 143.5K |
| Rev Growth | -16.7% | -16.7% | +6.7% |
| Debt/Equity | 0.03 | 0.03 | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,368.84 | +0.30% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $274.87 | +0.94% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $147.01 | +0.05% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.30 | -1.94% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $62.89 | -0.38% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $79.81 | -2.80% | 12.3 | 32.24B |